Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Effimune S.A.S.
DescriptionAnti CD-127 antibody
Molecular Target Interleukin-7 (IL-7) receptor (CD127)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard Indication Transplant (unspecified)
Indication DetailsPrevent transplant rejection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today